Balboa Wealth Partners’s Langar Global HealthTech ETF LGHT Stock Holding History

Balboa Wealth Partners’s Portfolio LGHT Stock Details LGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,190	Closed	-$123K	–	445
2025 Q3	$123K	Sell	12,190 -2,855	-19%	-$29.4K	0.02%	356
2025 Q2	$157K	Buy	15,045 +25	+0.2%	+$248	0.03%	327
2025 Q1	$147K	Buy	+15,020	New	+$159K	0.04%	273

Other funds holding LGHT

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

INVST Indianapolis, Indiana $1.03B AUM 29.49% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Balboa Wealth Partners's LGHT Position: Q4 2025 in Review

Balboa Wealth Partners sold out of Langar Global HealthTech ETF (LGHT) in Q4 2025, closing a stake of 12,190 shares — an estimated $123K sold.

Balboa Wealth Partners first reported a position in LGHT in Q1 2025 and held it in 3 quarters. The position peaked at $157K in Q2 2025. 5 funds tracked by Wall St. Rank hold LGHT as of Q4 2025.

Balboa Wealth Partners reported no remaining Langar Global HealthTech ETF position as of Q4 2025 after selling out during the quarter.
Balboa Wealth Partners sold 12,190 Langar Global HealthTech ETF shares in Q4 2025, an estimated $123K.
Balboa Wealth Partners first reported a position in Langar Global HealthTech ETF in Q1 2025 and held it in 3 quarters.
Balboa Wealth Partners's Langar Global HealthTech ETF position peaked at $157K in Q2 2025.
5 funds tracked by Wall St. Rank held Langar Global HealthTech ETF as of Q4 2025.

Based on Balboa Wealth Partners's 13F filing for Q4 2025, filed 16 Jan 2026.